Table 3 Characteristics of axSpA patients and supervising PTs at baseline
Characteristics | Total | Group 1 | Group 2 | Group 3 | Group 4 |
|---|---|---|---|---|---|
Patients with axSpA | |||||
Total number per group (n) | 43 | 8 | 11 | 8 | 16 |
Number participating in “moveSVMB” (n) | 30 | 3 | 6 | 7 | 14 |
Gender, women, n (%) | 10 (33.3) | 1 (33.3) | 2 (33.3) | 2 (28.5) | 5 (35.7) |
Years of age (median, range) | 57.5 (37–75) | 68 (37–72) | 58 (51–71) | 57 (45–68) | 56.5 (49–75) |
Disease duration, years (median, range) | 30 (12–60) | 49 (23–51) | 33 (20–46) | 30 (18–35) | 30 (12–60) |
ASAS-HI (median, range) | 2.1 (0–11) | 1 (0–3) | 2.1 (0–6) | 2 (0–8) | 3 (0–11) |
Physical activity level (IPAQ), total MET per week (median, range) | 3919 (1520–14,958) | 3916 (2526–6933) | 5820 (2298–10,260) | 2697 (1600–10,638) | 2853 (1520–14,958) |
Supervising PTs (n = 4) | |||||
PT group leader, gender (female/male) | – | f | f | f | m |
PT group leader, age, years (median, range) | 48.2 (34–54) | 52 | 45 | 34 | 54 |
PT group leader since, years (median, range) | 12 (2–23) | 23 | 8 | 2 | 16 |